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ABSTRACT

Acinetobacter baumannii is an opportunistic gram-negative bacterial pathogen that causes
many nosocomial infections in immunocompromised individuals. Common infections include
catheter-associated urinary tract infections, ventilator-associated pneumonia, skin and soft tissue
infections, and bloodstream infections that often lead to septicemia. Increasing multidrug
resistance (MDR) in A. baumannii warrants new approaches to understanding its virulence
mechanisms and pathogenicity. As a first step in infection, A. baumannii can attach to host cells,
providing a surface for the bacteria to grow and perhaps facilitating biofilm formation and
subsequent tissue invasion. In this study, we evaluated antibiotic resistance and characterized
biofilm formation, attachment, invasion, and surface protein RNA transcription profiles of A.
baumannii clinical isolates. Some isolates were resistant to commonly prescribed antibiotics, with
six of the seventeen showing MDR. We found that 16 of the 17 strains produce biofilms in varying
amounts; all strains were able to adhere to and invade A549 pulmonary cells in high levels; and
some of the strains exhibited genes associated with biofilm formation, attachment, and invasion.
Levels of biofilm formation, attachment to A549 cells, and invasion of A549 were not associated
with the presence or absence of target genes ompA, abaI, pga operon, bap, csuE, or blaPER-1.
Virulence of A. baumannii clinical isolates increases due to their ability to produce biofilms and
to attach to and invade host cells. It is important to elucidate further mechanisms of virulence in
order to better treat A. baumannii infections and to prevent transmission and future outbreaks. We
aimed to elucidate new information on the pathogenicity of A. baumannii that could lead to new
therapeutic treatments for these infections.

INDEX WORDS: Acinetobacter baumannii, biofilm formation, attachment, invasion, ompA, abaI,
pga operon, bap, csuE, blaPER-1
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INTRODUCTION

Acinetobacter baumannii is a gram-negative bacterium commonly found on the skin, in the
soil, and on abiotic surfaces such as plastics, counters, and floors (King et al., 2013). It can
normally inhabit healthy people as a commensal. In individuals with compromised immune
systems, however, A. baumannii can cause severe infections such as urinary tract infections,
pneumonia, bacteremia, bronchitis, meningitis, and skin infections (Loehfelm et al., 2007). These
infections can be life-threatening and difficult to treat, especially in the elderly population.
During the Iraq war, there was an increase in A. baumannii infections among wounded
soldiers, gaining it the nickname “Iraqibacter” (Maragakis and Perl, 2008). In 2017, the World
Health Organization named A. baumannii at the top of its clinical priority list for the development
of novel treatments. The rise of multi-drug resistant (MDR) A. baumannii strains necessitates new
treatments and preventative measures to combat outbreaks. There are approximately 45,000
Acinetobacter infections in the U.S. every year and more than 1 million cases globally (Spellberg
and Rex, 2013). Mortality rates due to A. baumannii infections have risen in recent years; twentythree percent of hospitalized patients and 43% of patients in intensive care units infected with A.
baumannii die from those infections (Falagas et al., 2006).

Transmission
A. baumannii has the ability to persist on environmental surfaces for long periods of time
(Maragakis and Perl, 2008; McDonald et. al, 1999). In some cases, it has been found viable on
surfaces months or even years after an outbreak has occurred (Fournier and Richet, 2006; Houang
et al., 1998). This poses a particular problem in hospital settings because of high patient turnover

2
and the need to disinfect surfaces between patients to prevent transmission. Its ability to persist on
abiotic surfaces makes A. baumannii readily transmissible from patient to patient, as well as from
healthcare worker to patient. This creates situations in which outbreaks are imminent and makes
current outbreaks very difficult to contain.
A. baumannii is normally transmitted to patients by contaminated hands of healthcare
workers and contaminated surfaces. In some cases, however, A. baumannii can be transmitted
through the air around infected individuals. One study found that nearly 25% of infected patients’
rooms contained air contaminated with carbapenem-resistant A. baumannii (CRAB). All patients
in the study were infected with CRAB and no contamination was found in the airducts, suggesting
it originated with the patients (Munoz-Price et al., 2013; Spellberg and Bonomo, 2013).
A. baumannii is also resistant to disinfection, and treatment with ethanol has been shown
to result in increased tolerance of high salinity environments and increased virulence in vivo as
shown in Galleria larvae, a type of moth used for bacterial animal infection models (Smith et al.,
2004; Nwugo et al., 2012). Ethanol is commonly used for disinfecting surfaces and has previously
been thought of as a very effective disinfectant. This study with Galleria shows that ethanol is not
necessarily as effective as it was once regarded. In some cases, like this study showed, ethanol
could aid in bacterial persistence by increasing its tolerance to a wider range of environments and
make disinfecting patient’s rooms ineffective.
RecA is an enzyme in A. baumannii that repairs damaged DNA, including that caused by
desiccation, high heat, or oxidative burst following phagocytosis by macrophages, thereby playing
a role in resistance to killing by macrophages and resistance to desiccation (Aranda et al., 2011).
These characteristics together with the increase in MDR strains make A. baumannii infections
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difficult to treat and even more difficult to contain when outbreaks occur, often within intensive
care units (Maragakis and Perl, 2008).
Persistence, Pathogenesis, and Virulence Mechanisms
A. baumannii has the ability to readily absorb DNA from the environment and incorporate
it into its genome, a bacterial phenomenon known as transformation. Bacteria with the ability to
do this are termed as competent cells. A. baumannii also has the ability to acquire new resistance
genes from nearby bacteria by transfer of plasmids via a sex pilus. This is known as conjugation
(McQueary and Actis, 2011). R-plasmids are short, circular segments of DNA that can be
transferred between bacterial species through conjugation. Antimicrobial resistance genes are
commonly transferred through this mechanism, creating novel antibiotic resistant strains instantly.
Furthermore, colonization of a host normally involves multiple genera and species of bacteria
which may provide access to genes from other MDR organisms (Burton's Microbiology for the
Health Sciences Tenth Edition, 2015). Patients who have undergone extensive antibiotic treatment
are at increased risk for A. baumannii infections due to decreased competition from other
commensal bacterial species and, because A. baumannii persists on surfaces for an extraordinary
amount of time after an outbreak, MDR strains can readily spread from patient to patient (Aranda
et al., 2011).
Biofilm formation is another important virulence mechanism in A. baumannii. Biofilms are
composed of bacterial cells which adhere to a surface and produce an extracellular polysaccharide
matrix that effectively protects the bacteria from antibiotic treatment and host immune responses
(King et al., 2013). These biofilms also contribute to antibiotic resistance and immune evasion by
shielding the bacteria from treatment (King et al., 2013; McQueary and Actis, 2011). Patients
being treated within a hospital are at elevated risk of acquiring A. baumannii infections for many
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reasons. Indwelling devices such as urinary catheters, ventilators, and intravenous devices provide
a mode of entry into the body and a surface on which pathogenic bacteria may attach and produce
biofilms (Costerton et al., 1999; Donlan and Costerton, 2002).
Many patients admitted to hospitals and ICUs also have compromised immune systems
compounded with the problem of preexisting diseases. Furthermore, nosocomial strains— those
found in a hospital setting— are more likely to be MDR and can make hospital-acquired infections
extremely difficult to treat and to contain (Costerton et al., 1999; McQueary and Actis, 2011).
An observational study examining ICU patients who had been intubated with endotracheal
tubes (ETTs) monitored and tested tubes for biofilm formation. Multi-species biofilms were found
on the ETTs in 71 out of 75 patients. A. baumannii composed 32% of the isolated biofilms, and
mature biofilms were found on ETTs as soon as 24 hours after intubation (Gil-Perotin et al., 2012).
They also found that biofilm formation was not associated with antibiotic treatment, length of
hospital stay, immunosuppression, or selective digestive tract decontamination as a preventative
treatment. Additionally, A. baumannii, along with Pseudomonas aeruginosa, persisted in 78% of
patients with ventilator-associated pneumonia following broad-spectrum antibiotic treatment.
Another study performed by Wand et al. found that differences in biofilm formation
between A. baumannii strains did not correlate with virulence in Galleria moth larvae but that
dispersed bacteria harvested from fully formed biofilms were more virulent than bacteria grown
planktonically (Wand et al., 2012). This suggests that different virulence mechanisms are acquired
or expressed within a biofilm than in planktonic form. Another study by Rumbo-Feal et al.
studying gene expression found 1621 genes that were overexpressed when A. baumannii was
grown in biofilms including 55 genes expressed exclusively in biofilm-associated bacteria (2013).
Many proteins associated with virulence were found to be upregulated in biofilm formation
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including Csu pili proteins, efflux pump proteins, and secretion proteins (Rumbo-Feal et al., 2013).
Furthermore, these studies indicate that it is not the amount of biofilm produced that affects
virulence, but merely the presence of biofilm that establishes higher virulence.
Host cell adherence and subsequent invasion are important first steps in infection (Beachey,
1981). Many clinical isolates have the ability to attach to host cells but only some have the ability
to invade host cells (Choi et al., 2008). Bacterial invasion of host cells provides protection from
host immune factors, allowing pathogens such as A. baumannii to persist in the host (Choi et al.,
2008). It is currently unclear, however, whether host cell attachment and invasion correlates with
virulence in A. baumannii (Wand et al., 2012; Zimbler et al., 2013; Giannouli et al., 2013).

Immune Evasion
The host innate immune system is imperative in clearing A. baumannii infections.
Together, three innate immune mechanisms—neutrophil killing, macrophage clearance, and
killing by complement—combat and clear the pathogen, preventing spread of the infection (Bruhn
et al., 2015). In strains with specialized capsules, however, some MDR strains have become
resistant to complement activity (King et al., 2013; Bruhn et al., 2015). Capsules are a
polysaccharide-based structure that coats the outside of some bacterial cells and protects them
from immune detection. There has also been a rise in strains resistant to macrophage and neutrophil
clearance and it is hypothesized that the capsule plays a large role in evasion of neutrophil and
macrophage activities (Bruhn et al., 2015).
Without intact innate immune defenses, infections with A. baumannii can progress to
sepsis, characterized by a “cytokine storm” caused by lipopolysaccharide (LPS), otherwise known
as endotoxin (Bruhn et al., 2015). In gram negative bacteria, LPS is embedded in the cell
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membrane with a portion that extends into the extracellular matrix where the host immune system
recognizes LPS as foreign and mounts an immune response against it. In cases of septic shock,
gram negative organisms have replicated in the blood and LPS binds to toll-like receptors (TLRs)
on dendritic cells and macrophages resulting in over-production of cytokines including interleukin
1 beta (IL-1b) and tumor necrosis factor alpha (TNF-a). Upregulation of these two cytokines
causes massive, wide-spread inflammation that leads to hypotension, fever, diarrhea, sporadic
blood clotting, and organ failure (Kuby Immunology Seventh Edition pg 135, 2018). If left
untreated, septic shock can result in death (Bruhn et al., 2015; Wong et al., 2017). Recent mortality
rates for patients suffering from septic shock have reached approximately 40% (Mayo Clinic,
2018).
Neutrophils are also crucial to an effective immune response. In one study, investigators
found phenylalanine presence to be crucial to neutrophil recruitment to the site of A. baumannii
infection in zebrafish. Strains that express the paaA gene have the ability to catabolize
phenylalanine and, as phenylalanine is broken down rapidly, fewer neutrophils are recruited to the
infection site. This could be an important virulence mechanism to evade host innate immune
responses (Bhuiyan et al., 2016). Lastly, A. baumannii is particularly motile and can evade
macrophage and neutrophil killing simply by “out-running” the immune cells (McConnell et al.,
2013; Clemmer et al., 2011).

Genes and proteins involved in biofilm formation, adherence, and invasion
Many proteins have been implicated in biofilm formation in Acinetobacter baumannii
including CsuA/BABCDE pilus usher-chaperone assembly system proteins, biofilm-associated
protein (Bap), and outer membrane protein A (OmpA) (Pakharukova et al., 2018; Breij et al.,
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2009). The Csu pilus consists of four protein subunits and has been shown to be involved in
attachment to abiotic substrates (Pakharukova et al., 2018). The subunit forming the tip of pili,
CsuE, creates three finger-like loops that attach to hydrophobic surfaces such as the plastics that
constitute indwelling devices residing in hospitalized patients. This is important for A. baumannii
attachment to and biofilm formation on other surfaces in hospitals as well such as plastic containers
and gloves. It has been shown that deletion of CsuE led to significantly decreased biofilm
formation on plastics as compared to the wildtype (Pakharukova et al., 2018). It has also been
shown that the Csu pili is not involved in adherence to epithelial cells (Breji et al., 2009).
Another set of genes associated with virulence and biofilm formation is the pgaABCD
operon which controls poly-β-1,6-Nacetylglucosamine (PNAG) synthesis. Under stressful
environmental conditions, the synthesis of peptidoglycan is upregulated via increased transcription
of the pgaABCD operon and results in a thicker cell wall for protection and desiccation resistance
(Choi et al., 2009). It has also been shown to play a significant role in colony adherence to abiotic
surfaces to allow for biofilm production (Bossé et al., 2010).
A homolog of Bap originally characterized in Staphylococcus aureus has been found in
many clinical isolates of A. baumannii (Loehfelm et al., 2007). It is involved in intracellular
cohesion within a biofilm and is imperative to forming mature biofilm. In a bap-deficient mutant,
biofilm formation decreased and biofilms were unable to reach maturity. Loehfelm et al. screened
98 strains isolated from infected soldiers overseas and 43% of the strains were positive for bap
(2007). Bap has also been shown to play a role in attachment to human cells. Brossard and
Campagnari showed that a bap-deficient mutant had both decreased biofilm formation and
decreased attachment to normal human bronchial epithelial and normal human neonatal
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keratinocyte cells (2011). This indicates that Bap may play a role in binding to host cells and this
adhesion may be related to higher biofilm production on host tissues as well as on abiotic surfaces.
Other proteins have been implicated in cell attachment and invasion as well. OmpA has
been associated with attachment to and invasion of host cells (Choi et al., 2008; Choi et al., 2005).
In a study performed by Gaddy et al., they found that OmpA plays a role in biofilm formation and
is required for attachment to A549 cells (2009). Another protein, PER-1, has been linked to
adhesion to bronchial cells and may aid in invasion of host cells (Lee et al., 2008). AbaI is an
autoinducer synthase involved in quorum sensing (Niu et al., 2008). It is has also been shown to
play a necessary role in biofilm formation and may play an important role in the late stages of
biofilm maturation and attachment (Lui et al., 2016). Many studies have investigated adhesion and
invasion of host cells using laboratory strains, but few studies have characterized clinical
specimens with these genes.
Lui et al. performed a retroactive study in China in which 122 sputum samples were
collected from patients with A. baumannii infections (2016). Of the 122 clinical isolates collected,
abaI and csuE were detected in 59.8%, ompA was detected in 100%, and blaPER-1 was not detected
in any isolates. This study compared four biofilm-related genes and antibiotic resistance. They did
not characterize biofilm formation or investigate bacterial adhesion or invasion. There have been
no such studies to date that have characterized biofilm formation, adhesion to host cells, invasion
of host cells, and presence of genes related to these virulence mechanisms in a large cohort of
clinical strains of A. baumannii.
The purpose of this study was to characterize biofilm formation, attachment to and invasion
of human cells, and to investigate the presence of genes encoding surface proteins shown to be
involved in these virulence mechanisms of 17 A. baumannii clinical isolates (Table 1). The surface
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protein RNA transcription profiles included screening for presence of genes encoding
CsuABABCDE, Bap, PER-1, AbaI, Pga loci, and OmpA. By assessing the presence and
transcription of these genes associated with biofilm formation, adherence, and invasion, we can
better understand the complex virulence seen in A. baumannii. Many virulence mechanisms of A.
baumannii are still not well understood and elucidating these mechanisms could lead to discovery
of new treatments for A. baumannii infections.

METHODS

Clinical Isolates. 17 clinical isolates of A. baumannii were obtained from St. Francis Hospital in
Columbus, Georgia. Identification and antibiotic susceptibility testing were performed on each
strain at St. Francis Hospital using a MicroScan WalkAway 96 plus System Instrument (Beckman
Coulter). Each isolate was grown overnight in 10 ml of LB broth and aliquots were frozen in midlog phase in 20% glycerol for later use. Each isolate was renamed in the order they were acquired:
SF1-17. Six of the 17 isolates were resistant to three or more tested antibiotics and deemed MDR
isolates (Table 1). The location that each strain was isolated from on patients and name of the
clinical isolate are listed in Table 1.

Inoculum Preparation. A. baumannii was thawed from freezer stock and grown overnight on
MacConkey agar at 37°C. Twenty-four hours following, 10 ml of LB broth was inoculated and
incubated overnight for approximately 12-18 hours at 37°C. Absorbance measurements of inocula
were read at an OD600 with a BioRad microplate spectrophotometer until mid-log phase was
reached at an OD600 of 0.2-0.3. Aliquots of mid-log phase bacteria were frozen at -80°C, thawed,
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and plated for CFU/ml enumeration. The quantified aliquots of A. baumannii isolates were used
to standardize the number of bacteria used in adhesion and invasion assays. Each assay was
performed in triplicate with five or three biological replicates.

Biofilm Crystal Violet Assay. Fifty µl of mid-log bacterial inoculum and 50 µl of sterile LB broth
was added to the wells of a 96-well plate and incubated for 24 hours at 37°C. Following the
incubation, wells were washed four times with distilled water, stained with 100 µl of 0.1% crystal
violet, and incubated for 30 minutes at room temperature. Wells were again washed four times
with distilled water and trapped crystal violet was eluted with 200 µl of 95% ethanol. 125µl of this
eluent was transferred to a fresh plate, and the absorbance was read at 570 nm using a BioRad
microplate spectrophotometer (King et al., 2013). Assays were done in triplicate with a total of
five biological replicates. Absorbance measurements were analyzed using a one-way ANOVA and
Tukey’s test of multiple comparisons.

Tissue Culture Preparation. Cells of the human alveolar epithelial cell line A549 (ATCC CCL185) were cultured in a T-75 culture flask at 37°C in Dulbecco’s Modified Eagles Medium
(DMEM) (Gibco BRL), supplemented with 2 mM L-glutamine, 1% PenStrep, and 10% fetal
bovine serum (Gibco BRL), in a humidified atmosphere containing 5% CO2. Cells were
subcultured when reaching approximately 90% confluency. A549 cells used in assays were seeded
at passage three and used for all assays.

Adhesion Assay. A549 cells in a T-75 flask were washed two times with Hank’s Balanced Salt
Solution (HBSS) (Colonetics) prewarmed to 37°C to remove drug media. Cells were then lifted
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with 0.25% Trypsin-EDTA solution in HBSS (Sigma-Aldrich) and incubated at 37°C with 5%
CO2 for 20 minutes or until cells lifted. 1x105 A549 cells were added to the wells of a 12-well tissue
culture plate (Fisherbrand™) and allowed to adhere for 24 hours at 37°C with 5% CO2. Cells were
washed two times with HBSS and 1x107 bacteria suspended in 1 ml of drug-free DMEM
(dfDMEM) with 10% fetal calf serum (FCS) was added to each respective well and incubated for
30, 90, and 180 minutes at 37°C with 5% CO2 (Brossard and Campagnari, 2011). Following
incubation, cells were washed three times with HBSS and cells were lifted with 500 µl of 0.25%
Trypsin-EDTA solution. 500 µl of dfDMEM was added to the 500 µl of trypsinized cells in the
wells, serially diluted, and plated on MacConkey agar for colony-forming units per ml (CFU/ml)
enumeration. Adhesion assays were performed in triplicate with three biological replicates. Values
were analyzed using a One-way ANOVA and Tukey’s test of multiple comparisons (SPSS).

Invasion Assay. 1x105 A549 cells were added to the wells of a 12-well tissue culture plate
(Fisherbrand™) and allowed to adhere for 24 hours at 37°C with 5% CO2. A549 cells were washed
with dfDMEM and inoculated with 1x107 bacterial cells. Samples were incubated for 180 and 300
minutes at 37°C with 5% CO2. Following incubation, the wells were treated with 300 µg/ml of
Amikacin (SF1-SF14, SF16 and SF17) or 300 µg/ml of Ceftazidime (SF15) dissolved in dfDMEM
and incubated for one hour to kill extracellular bacteria. Ceftazidime was used on SF15 due to
resistance of the isolate to all other tested antibiotics. Wells were then washed two times with
HBSS and A549 cells were lifted with 500 µl of 0.25% Trypsin-EDTA solution and incubated for
20 minutes or until cells lifted. Cells were lysed with 500 µl of 1.0% saponin solution, 500 µl of
dfDMEM was added to the cells, and samples were serially diluted and plated on MacConkey agar
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for CFU/ml enumeration (Brossard and Campagnari, 2011). Values were analyzed using a Oneway ANOVA and Tukey’s test of multiple comparisons (SPSS).

PCR Analysis. Target genes were detected using colony polymerase chain reaction (colony PCR)
using Go Taq™ Master Mix (Promega™) following manufacturer protocols. In short, one colony
of bacteria was added to a reaction with dNTPs, Taq DNA polymerase, forward and reverse
primers, and reaction buffer. The reaction mixture was placed in a thermocycler and set with the
following PCR cycling parameters. The various target gene primer sequences and product lengths
used are shown in Table 2. Each amplification reaction included 2.5 ul of forward and reverse
primers (10 nM concentration) and approximately one colony of the respective clinical isolate.
The PCR thermal cycling parameters for abaI and csuE were an initial denaturation at 95°C for 10
minutes; followed by 35 cycles of 95°C for 30 seconds, 63°C for 30 seconds, and 72°C for 1
minute; and a final extension at 72°C for 10 minutes (Lui et al., 2016). The PCR thermal cycling
parameters for ompA and blaPER-1 were an initial denaturation at 95°C for 10 minutes; followed by
35 cycles of 95°C for 30 seconds, 52°C for 30 seconds, and 72°C for 1 minute; and a final extension
at 72°C for 10 minutes (Lui et al., 2016). The PCR thermal cycling parameters for bap were an
initial denaturation at 95°C for 10 minutes; followed by 30 cycles of 95°C for 30 minute seconds,
temperature gradient ranging from 50-60°C for 30 seconds per temperature, and 72°C for 1 minute;
and a final extension at 72°C for 10 minutes (Loehfelm et al., 2007). The PCR thermal cycling
parameters for the pga locus were an initial denaturation at 95°C for 10 minutes; followed by 30
cycles of 95°C for 30 minute seconds, temperature gradient ranging from 55-65°C for 30 seconds
per temperature each cycle, and 72°C for 1 minute; and a final extension at 72°C for 10 minutes
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(Choi et al., 2009). DNA bands were visualized using a Bio-Rad GelDoc Imaging System. By
comparing the resulting bands and a DNA base pair marker following 1% agarose gel
electrophoresis, products that showed the expected molecular weight were regarded as positive.

Reverse-transcription PCR. Primers listed in Table 2 were used for RT-PCR. Total RNA was
isolated with PureLink™ RNA Mini Kit (Invitrogen™) following manufacturer protocols. RNA
was treated with DNase and RT-PCR was performed on isolates positive for presence of the target
genes using SuperScript™ IV One-Step RT-PCR System (Invitrogen™) following manufacturers
protocol. The RT-PCR thermal cycling parameters were the same as above with an added reversetranscription step at 55°C for 10 min before starting the initial denaturation step. cDNA of
transcripts of target genes were analyzed on 1% agarose gel by gel electrophoresis. DNA bands
were visualized using a Bio-Rad GelDoc Imaging System. Products that showed the expected
molecular weight were regarded as positive for presence of the target gene transcript.

RESULTS

Clinical Isolates Produce Biofilm on Polystyrene
Most clinical isolates produced biofilms to some extent, with 13 strains producing low amounts of
biofilm and 1 strain producing no biofilm (Figure 1). SF9 and SF17 produced significantly more
biofilm than all other isolates (One-way ANOVA, F16, 238= 58.02, P<0.0001; Figure 1). SF10
produced significantly more biofilm than SF2, SF4, SF5, SF6, SF11, SF12, SF14, SF15, and SF16
(One-way ANOVA, F16, 238= 58.02, P<0.0001; Figure 1). All other strains showed no significant

14
difference in biofilm formation when compared to one another. SF16 produced such a small
amount of biofilm that it was characterized as producing none.

Clinical Strains Adhere to A549 Cells
All clinical isolates were able to adhere to A549 cells in high levels (Figure 2). SF2 and SF13
adhered in significantly higher amounts than all other strains (One-way ANOVA, F16, 136 = 21.34,
P <0.0001; Figure 2). SF2 also exhibited higher adherence to pulmonary cells than most isolates
with the exception of SF1, SF4, SF13, and SF15 (One-way ANOVA, F16, 136 = 21.34, P <0.0001;
Figure 2). SF1 and SF4 all exhibited higher adherence to A549 cells than 7 of the 17 isolates. SF3
exhibited significantly lower adherence than all isolates except SF5, SF6, SF7, SF11, and SF 12.
SF 12 exhibited significantly lower adherence to pulmonary cells than all isolates except for SF3
and SF5 (One-way ANOVA, F16, 136 = 21.34, P <0.0001; Figure 2). While all strains were able to
adhere to pulmonary cells in high amounts, based on these results, we have designated SF1, SF2,
SF4, SF13, and SF15 as more highly adherent than other strains and SF3 and SF12 as less adherent
than other strains.

Clinical Strains Invade A549 Cells
All clinical strains were able to invade A549 pulmonary cells in high numbers (Figure 3). SF10
was significantly more invasive than 11 (SF1, SF2, SF3, SF4, SF7, SF8, SF9, SF11, SF12, SF14,
SF16, SF17) of the 17 isolates (One-way ANOVA, F16, 136 =10.31, P <0.0001; Figure 3). SF3 was
significantly less invasive than all other isolates except for SF1, SF12, and SF14. Based on the
results, SF1, SF3, SF12, and SF14 exhibited low levels of invasion and SF5, SF6, SF10, SF13,
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and SF15 exhibited high levels of invasion. All other isolates—SF2, SF4, SF7, SF8, SF9, SF11,
and SF14— did not exhibit a significant pattern when compared to invasion of other isolates.

Some Clinical Isolates Encode Target Genes
Based on colony PCR and gel electrophoresis, SF1, SF2, SF13, SF15, and SF17 do not encode any
of the target genes. OmpA was present in 7 of the 17 (41%) isolates (Figure 4 and Table 3). AbaI
was present in 9 of the 17 (53%) isolates. CsuE was present in 3 (17.6%) of the isolates. Bap was
present in 1 isolate. The pga locus was present in 7 (41%) of the isolates. No clinical strains
exhibited presence of the blaPER-1 gene.

Some Clinical Isolates Demonstrate Presence of Target Genes
RT-PCR was done on representative isolates to determine the presence of mRNA transcripts when
grown planktonically All isolates exhibited cDNA products of target mRNA except for ompA in
SF14 (Figure 5 and Table 4). OmpA was absent in SF14, which could indicate that the gene was
not transcribed when grown in suspension.

DISCUSSION

Acinetobacter baumannii has risen in clinical relevance over the last two decades. A.
baumannii’s ability to resist killing by disinfectants, killing by antibiotic treatment, and killing by
the immune system makes it a clinical priority in need of novel therapies and treatments. With the
increase in A. baumannii cases in hospitals, it is imperative that we elucidate new possible
virulence mechanisms that could lead to new treatments. Past research has investigated biofilm
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production and attachment to pulmonary epithelial cells in lab strains of A. baumannii, but research
has yet to be done on clinically relevant strains of A. baumannii. In this study, we aimed to
characterize biofilm production, adhesion to human pulmonary cells, invasion of pulmonary cells,
and to identify the presence of target genes associated with biofilm, attachment, and invasion in
17 clinical isolates of A. baumannii.
Many previous studies have demonstrated the ability of A. baumannii to produce biofilms
on abiotic and biotic surfaces (King et al., 2013; King et al., 2014; McQueary and Actis, 2011;
Costerton et al., 1999; Donlan and Costerton, 2002; Bossé et al., 2010; Loehfelm et al., 2007).
Some of these studies have also suggested an association between the presence of genes like ompA,
bap, blaPER-1, abaI, pga operon, and csuA/BABCDE and increased biofilm formation. Results of
our study confirm that 16 of the 17 clinical specimens obtained from infected patients were able
to produce biofilms, with 3 (SF9, SF10, and SF17) of the isolates producing significantly more
than the rest. Biofilms are an important virulence mechanism. They provide protection from the
external environment, desiccation, antibiotics, and host defenses (McQueary and Actis, 2011).
Biofilm production in 16 of our clinical isolates demonstrates the prevalence of biofilms in
nosocomial strains of A. baumannii. The ability of these strains to produce biofilm makes
subsequent infections caused by strains difficult to treat in hospitalized patients. The prevalence
of plastics and metal surfaces is widespread in hospitals, providing surfaces for pathogenic strains
of A. baumannii to attach to and produce biofilms.
As mentioned previously, the mere presence of biofilm is enough to increase virulence of
clinical strains (Wand et al., 2012; Rumbo-Feal et al., 2013). In some cases, sensitivity of the
strains to antibiotics is irrelevant, as the biofilm protects the bacteria from antibiotic penetration
(Wand et al., 2012; Rumbo-Feal et al., 2013). This is especially relevant with our cohort of clinical
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isolates since 11 of the 16 biofilm-producing strains were sensitive to most commonly prescribed
antibiotics in planktonic form (Table 1). This suggests that these infections may be more difficult
to treat when forming a biofilm and may be more readily transmissible from patient to patient,
making outbreaks difficult to contain.
Our results further suggest the presence or absence of biofilm is not associated with any of
the target genes, in contrast with previous studies (Pakharukova et al., 2018; Breij et al., 2009).
Biofilms are complex and many proteins are involved in their formation. Because of the wide
heterogeneity between strains of A. baumannii, it is a possibility that conclusions of previous
studies were specific to the strains used in the studies. Furthermore, many studies testing genedeficient mutants were performed using lab strains of A. baumannii. With rapid bacterial evolution
and the high level of competence—gene transfer between bacterial strains and species—seen in A.
baumannii, these lab strains may not be representative of the current population of A. baumannii
strains seen in hospitals today.
Many lab strains of A. baumannii have been found to adhere to pulmonary cells, and it is
widely acknowledged that attachment to host cells is the first step in infection (Beachey, 1981;
Wand et al., 2012; Zimbler et al., 2013; Giannouli et al., 2013). This study demonstrates the ability
of A. baumannii clinical strains to adhere to A549 alveolar cells in vitro. There does not seem to
be an association, however, between the presence or absence of any of the target genes and
adhesion. Isolates without any of the target genes were still able to adhere to pulmonary cells. One
study found a positive correlation between biofilm production and attachment to host cells
(Brossard et al., 2011) but we did not observe that. The difference in results between their study
and this one could be attributed to a few key differences in their study design. Their study evaluated
adhesion of one strain of A. baumannii (Ab307) to two different primary cell lines: normal human
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bronchial epithelial cells and normal human neonatal keratinocytes. Eukaryotic cells express
different receptors and surface markers depending on the cell type and bacterial strains express
different proteins and adhesins that bind to cell surface markers on human cells (Kuby
Immunology Seventh Edition, 2018). Our study evaluated adhesion of a larger cohort of clinical
isolates to the A549 adenocarcinoma alveolar cell line. The inclusion of more clinical isolates, the
genetic diversity of A. baumannii clinical isolates, and the use of an alternative cell line could all
contribute to the divergence of our findings as compared to published findings. This study
demonstrates that the bacterial proteins that bind to eukaryotic cells have yet to be fully elucidated.
In the case of the Csu pili, it is specialized to bind to hydrophobic molecules like the ones found
in polystyrene, a plastic. Many human cell receptors are hydrophilic so the Csu pili will not bind
to them. In the same way, the target genes investigated in this study may not be the genes encoding
adhesins that bind to human epithelial cells.
OmpA has been shown to be involved in invasion of host cells. All clinical strains used in
this study were able to invade A549 pulmonary cells to high levels. This is a significant finding,
as most other studies have shown strains that were only mildly invasive (Breji et al., 2009; Breji
et al., 2010). Our study is the first to demonstrate a large cohort of clinical isolates of A. baumannii
invading pulmonary cells to a great degree. Attachment to and invasion of host cells are often the
first steps in infection. The ability to invade cells also increases the risk for systemic infection that
could lead to septicemia (Bruhn et al., 2015; Wong et al., 2017). It is also worth noting that all
isolates could invade host cells, regardless of the location at which the specimens were isolated.
Further elucidation with other cell types is needed. The ability to invade different types of host
epithelial cells without specificity to cell type could increase the virulence and transmissibility of
these isolates. These strains may have the ability to translocate in an infected patient or could be
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transmitted to another patient and cause a different infection (e.g. a strain causing ventilatorassociated pneumonia and then causing catheter-associated urinary tract infection in a different
individual).
While all strains were able to invade pulmonary cells at high levels, the level of invasion
did not appear to have an association with biofilm formation, adhesion, or presence of ompA or
other targets genes. It is worth noting that three of the 17 isolates exhibited both high levels of
adhesion and high levels of invasion of host cells (SF10, SF13, SF15). Two of these strains (SF13
and SF15) were isolated from patients with catheter-associated urinary tract infections, and both
of these isolates are MDR. Interestingly, two of the most adhesive and invasive isolates (SF13 and
SF15) do not contain any of the target genes. This further suggests the need for the elucidation of
more mechanisms of A. baumannii attachment to and invasion of host cells.
A. baumannii is an important pathogen in hospital settings, and novel therapeutic
approaches are required to combat these infections. The increase in antibiotic resistance among
bacterial species, especially in A. baumannii, has shifted the focus to the virulence of pathogens
and the mechanisms used to evade antimicrobial killing and host immune responses. This study
has shown the robustness of A. baumannii clinical isolates in their ability to produce different
levels of biofilm, adhere to and invade pulmonary cells, and the differences in gene presence. In
the future, a genome-wide assessment of gene targets could help elucidate the proteins involved in
adhering to and invading host cells. It is likely that there are multiple genes involved in these
processes and elucidating them could lead to the development of much-needed new treatments to
combat this global epidemic.
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Figure 1. Average absorbance (+/- 1 SD) of crystal violet at 570nm representing biofilm formation
of 17 St. Francis Clinical Strains. Isolates were grown to midlog phase, incubated in the wells of
a 96-well plate overnight, stained with crystal violet and eluted with ethanol. Absorbances were
read with a microtiter plate reader at a wavelength of 570nm. Absorbances were averaged and
analyzed using a one-way ANOVA and Tukey’s post-hoc test. Asterisks denote statistical
significance. (One-way ANOVA, F16, 238= 58.02, P<0.0001).
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Figure 2. Average log CFU/ml (+/-1 SD) of cell-associated bacteria. A549 cells were
inoculated with midlog bacteria at a MOI of 100:1 and incubated at 37°C for 30, 90, and 180
minutes. Average cell-associated log CFU/ml counts were averaged over the three time points
and analyzed using a one-way ANOVA and Tukey’s post-hoc test. Asterisks denote statistical
significance. (One-way ANOVA, F16, 136 = 21.34, P <0.0001).
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Figure 3. Average log CFU/ml (+/-1 SD) of invasive bacteria. A549 cells were inoculated with
midlog bacteria at a MOI of 100:1 and incubated at 37°C for 180 and 300 minutes. Cells were
treated with antibiotics and incubated for 1 hour to kill extracellular bacteria. Average
intracellular log CFU/ml counts were averaged over the two time points and analyzed using a
one-way ANOVA and Tukey’s post-hoc test of multiple comparisons. Asterisks denote
statistical significance. (One-way ANOVA, F16, 136 =10.31, P <0.0001).
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Figure 4. Colony PCR gel electrophoresis of target genes in 17 clinical isolates of A.
baumannii: csuE (A), abaI (B), blaPER1 (C), ompA (D), bap (E), and pga operon (F). Presence
of band at the correct molecular weight is considered positive.
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Figure 5. RT- PCR gel electrophoresis of target genes in 17 clinical strains of A. baumannii:
ompA and bap respectively (A), pga operon and abaI respectively (B), csuE (C) Presence of
a band at the correct molecular weight is considered positive for cDNA.
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Table 1. List of clinical isolates and locations of infections collected from patients at
St. Francis Hospital in Columbus, GA.
Isolate
SF 1
SF 2
SF 3
SF 4*
SF 5*
SF 6
SF 7
SF 8
SF 9
SF 10
SF 11*
SF 12
SF 13*
SF 14
SF 15*
SF 16*
SF 17
* Indicates MDR isolates.

Location of Infection
Otitis media
No data
Midstream urine
Midstream urine
Bronchial wash
Peritoneal fluid
Blood
Sputum
Wound
Wound/Ear
Bronchial wash
Cath urine
Cath urine
Wound
Cath urine
Wound
Bronchial Wash
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Table 2. List of oligonucleotide primers used in PCR and RT-PCR.
Gene
Primer
Product
Product
Primer Squence
Name
Length
Target
5' region of
1124
TCATACGTCTGAAAAATGGCGAG
bap
5' region of
1125
CATCAAGTGCTACTGTCGGCG
~1,019 bp
bap
ATGCATGTTCTCTGGACTGATGTT
csuE-1
csuE
GAC
CGACTTGTACCGTGACCGTATCT
csuE-2
csuE
~976 bp
TGATAAG
blaPERbla-PER1
ATGAATGTCATTATAAAAGC
11-1
bla-PERbla-PER1
AATTTGGGCTTAGGGCAGAA
~978 bp
1-2
ompA-1

ompA

CAATTGTTATCTCTGGAG

ompA-2

ompA

ACCTTGAGTAGACAAACGA

abaI-1

abaI

abaI-2

abaI

NdeI-Fpga
BmtI-Rpga

pga loci
pga loci

GTACAGTCGACGTATTTGTTGAA
TATTTGGG
CGTACGTCTAGAGTAATGAGTTG
TTTTGCGCC
GGGCCCCATATGTCGTATTTTAC
AAATGACA
GGGCCCGCTAGCACTTGACATAA
TAAACAGATAATCAG

~966 bp

~382 bp

~641 bp

Source
Loehfelm et
al., 2007
Loehfelm et
al., 2007
Lui et al.,
2016
Lui et al.,
2016
Lui et al.,
2016
Lui et al.,
2016
Lui et al.,
2016
Lui et al.,
2016
Lui et al.,
2016
Lui et al.,
2016
Choi et al.,
2009
Choi et al.,
2009
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Table 3. Colony PCR-indicated presence of target genes.
Clinical Isolate
SF1
SF2
SF3
SF4
SF5
SF6
SF7
SF8
SF9
SF10
SF11
SF12
SF13
SF14
SF15
SF16
SF17

abal csue ompa blaPER-1 bap pga

X
X
X
X

X

X
X
X

X

X
X
X

X
X
X
X
X

X

X
X
X

X
X

X

X

X
X
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Table 4. RT-PCR-indicated presence of target genes.
Clinical Isolate abal csue ompa bap pga
SF3
X
X
X
X
X
SF4
X
X
X
SF5
X
X
X
SF9
X
SF10
X
X
X
SF12
X
SF14
X
X
X
SF16
X
X
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